Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties - Proost, P; Schutyser, E; Menten, P; Struyf, S; Wuyts, A; Opdenakker, G; Detheux, M; Parmentier, M; Durinx, C; Lambeir, A M; Neyts, J; Liekens, S; Maudgal, P C; Billiau, A; Van Damme, J (Blood, 2001)